MedTrace Logo

A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

NCT07075627 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-08-04

No results posted yet for this study

Summary

This is a multi-center observational study in subjects with a diagnosis of small cell lung cancer. Screening and/or medical record review for symptoms associated with Lambert Eaton Myasthenic Syndrome (LEMS) will be conducted.

Conditions

  • Small Cell Lung Cancer ( SCLC )
  • Lambert Eaton Myasthenic Syndrome (LEMS)

Sponsors & Collaborators

  • Addario Lung Cancer Medical Institute

    lead OTHER

Principal Investigators

  • Jacob Sands, MD · Dana-Farber Cancer Institute

  • Gilbert Youssef, MD · Dana-Farber Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07075627 on ClinicalTrials.gov